KORU Medical Systems Inc. (KRMD)
NASDAQ: KRMDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
KRMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $138.37M
- Forward P/E
- 45.57
- EPS (TTM)
- -$0.02
- Dividend yield
- None
- 52-week range
- 2.86 – 6.61
- Day range
- 3.17 – 3.48
- Volume / Avg
- 320.88K / 223.45K
- Beta
- —
- Shares outstanding
- 43.38M
52-week range
KRMD stock today
On Nov 20, KRMD ended the session at $3.19, shedding $0.25 (7.27%), versus the S&P 500's 3.70% decline. At this level, KRMD sits near the bottom of its 52-week range of $2.86 to $6.61: 51.7% below the high, set on Dec 24, 2025 and 11.5% above the low. KRMD is down 45.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 33.3%.
KORU Medical Systems has posted a net loss over the last twelve months (EPS of -$0.02), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About KORU Medical Systems
Company profileKORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Adam Kalbermatten
- Headquarters
- Mahwah, NJ
- Employees
- 73
- Website
- korumedical.com
Financial highlights
Full financialsIn fiscal 2025, KORU Medical Systems generated $41.1 million in revenue, up 22.2% from fiscal 2024, its 4th consecutive year of revenue growth. KORU Medical Systems reported a net loss of $2.6 million, compared with a loss of $6.1 million a year earlier. Gross margin was 62.3% (down from 63.4%) and operating margin -7.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $41.13M | $33.65M | $28.52M | $27.90M | $23.49M |
| Growth | +22.23% | +17.98% | +2.23% | +18.76% | -2.84% |
| Net income | $-2.64M | $-6.07M | $-13.74M | $-8.66M | $-4.56M |
| EPS (diluted) | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 |
Analyst forecast
ForecastConsensus (4 analysts)
strong_buy
Avg. price target
$6.13+92.16%
- Strong buy 0
- Buy 3
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $0.00 vs $0.00
KRMD news
All KRMD news- KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDABusiness Wire
- KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026Business Wire
- Reasons to Retain Doximity Stock in Your Portfolio for NowNasdaqDOCS, WST, GMED, KRMD
KORU Medical Systems peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PYPDPolyPid Ltd. | 6.12 | -6.56% | $129.29M | vs KRMD |
| STIMNeuronetics Inc. | 1.25 | +0.81% | $120.60M | vs KRMD |
| LUNGPulmonx Corporation | 2.57 | -6.20% | $111.93M | vs KRMD |
| APYXApyx Medical Corporation | 2.40 | +0.42% | $101.10M | vs KRMD |
| ANIKAnika Therapeutics Inc. | 13.23 | -0.38% | $177.22M | vs KRMD |
| NYXHNyxoah SA | 0.805 | -7.01% | $81.98M | vs KRMD |
| UTMDUtah Medical Products Inc. | 69.49 | -2.07% | $198.01M | vs KRMD |
| SKINSkinHealth Systems Inc. Class A | 11.77 | -3.13% | $76.68M | vs KRMD |
Indexes, lists and sector
KORU Medical Systems stock FAQ
What is KORU Medical Systems's stock price today?
KRMD last traded at $3.19 as of Nov 20, 4:00 PM EST, down 7.27% on the day. Prices are delayed at least 15 minutes.
Who is KORU Medical Systems's CEO?
Mr. Adam Kalbermatten is the chief executive officer of KORU Medical Systems Inc., which has about 73 employees.
What is the KRMD 52-week high?
The 52-week high for KRMD is $6.61 and the 52-week low is $2.86. The stock is currently 51.7% below its high.